Manufacturer record

Amba Research Laboratories: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Amba Research Laboratories (Bihar) were declared Not of Standard Quality between March 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: AN-215, Adrenaline Bitartrate InJ. I.P. (exp Jul 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to IP with respect to test for "Particulate matter", "pH", "Assay/content of Adrenaline and is also not of. Listed in the September 2026 alert.

Records by type

3 records linked to Amba Research Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2025 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2025
3
Products affected
Assay
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2025 · 12026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Adrenaline Bitartrate InJ. I.P. Batch AN-215Mfg Feb 2026 · Exp Jul 2027 The sample does not conform to IP with respect to test for "Particulate matter", "pH", "Assay/content of Adrenaline and is also not of standard quality for the reason stated under "Description".Assay CDL, KolkataCDSCO lab Sep 2026
Vitamin B-complex with Lysin & Calcium Pantothenate Syrup 100 ml Batch BP-134Mfg May 2025 · Exp Oct 2026 The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Act 1940 with respect to Assay of Thiamine Hydrochloride.Assay CDL, KolkataCDSCO lab Apr 2026
Gentamicin Sulphate Injection IP (GENTAMICIN) Batch GN-37Mfg Sep 2024 · Exp Aug 2026 Sterility, Particulate Matter and DescriptionDescription CDL, KolkataCDSCO lab Mar 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.